The Patent Finder

Terms ending in 2040

AbbVie Inc.

Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US D1,065,814Carrying Pack for Medical Device
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US D1,066,015Container Cap
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 10,851,073Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof
In force
 · Medium confidence
Calico Life Sciences LLCIn forceMedium confidence
US D1,070,274Carrying Vest
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 12,715,916Anti-Hemojuvelin (HJV) Antibodies for Treating Myelofibrosis
In force
 · Medium confidence
AbbVie Deutschland GmbH & Co. KGIn forceMedium confidence
US 12,715,917Methods of Using Anti-Hemojuvelin (HJV) Antibodies for Treating Myelofibrosis
In force
 · Medium confidence
AbbVie Deutschland GmbH & Co. KGIn forceMedium confidence
US D1,076,063Infusion Pump
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 12,251,365Pharmaceutical Formulations for Subcutaneous Administration
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US D1,082,224Carrying Vest
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 11,690,845Methods of Administering Elagolix
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
1 more term end in 2040 · Pro
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11.
Upgrade to Pro
10 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited